Noninvasive assessment of characteristics of novel anti-HER2

Cancers, Free Full-Text

Frontiers Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer

Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer - ScienceDirect

Clinicopathological characteristics of the study population with

Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases - ScienceDirect

Patient-derived xenograft models in cancer therapy: technologies and applications

The landscape of d16HER2 splice variant expression across HER2-positive cancers

Diagnostics, Free Full-Text

Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options

IJMS, Free Full-Text